These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines. Naoi M, Maruyama W, Kasamatsu T, Dostert P. J Neural Transm Suppl; 1998 Jul; 52():125-38. PubMed ID: 9564615 [Abstract] [Full Text] [Related]
3. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells. Takahashi T, Maruyama W, Deng Y, Dostert P, Nakahara D, Niwa T, Ohta S, Naoi M. J Neural Transm (Vienna); 1997 Jul; 104(1):59-66. PubMed ID: 9085193 [Abstract] [Full Text] [Related]
4. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies. Maruyama W, Dostert P, Naoi M. J Neurochem; 1995 Jun; 64(6):2635-43. PubMed ID: 7760044 [Abstract] [Full Text] [Related]
5. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Naoi M, Maruyama W, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M. Brain Res; 1996 Feb 19; 709(2):285-95. PubMed ID: 8833765 [Abstract] [Full Text] [Related]
6. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells. Maruyama W, Naoi M, Kasamatsu T, Hashizume Y, Takahashi T, Kohda K, Dostert P. J Neurochem; 1997 Jul 19; 69(1):322-9. PubMed ID: 9202326 [Abstract] [Full Text] [Related]
7. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain. Maruyama W, Sobue G, Matsubara K, Hashizume Y, Dostert P, Naoi M. Neurosci Lett; 1997 Feb 14; 223(1):61-4. PubMed ID: 9058423 [Abstract] [Full Text] [Related]
8. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Naoi M, Maruyama W, Nagy GM. Neurotoxicology; 2004 Jan 14; 25(1-2):193-204. PubMed ID: 14697894 [Abstract] [Full Text] [Related]
9. Contrasting effects of catecholic and O-methylated tetrahydroisoquinolines on hydroxyl radical production. Nappi AJ, Vass E, Collins MA. Biochim Biophys Acta; 1999 Sep 14; 1434(1):64-73. PubMed ID: 10556560 [Abstract] [Full Text] [Related]
10. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease. Naoi M, Maruyama W, Akao Y, Yi H. Neurotoxicol Teratol; 2002 Sep 14; 24(5):579-91. PubMed ID: 12200189 [Abstract] [Full Text] [Related]
12. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease. Naoi M, Maruyama W, Dostert P, Hashizume Y. J Neural Transm Suppl; 1997 Sep 14; 50():89-105. PubMed ID: 9120428 [Abstract] [Full Text] [Related]
13. [Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease]. Maruyama W, Naoi M. Nihon Yakurigaku Zasshi; 2000 Dec 14; 116(6):333-42. PubMed ID: 11188501 [Abstract] [Full Text] [Related]
14. Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol. Xiong Q, Zheng X, Wang J, Chen Z, Deng Y, Zhong R, Wang J, Chen X. J Integr Neurosci; 2022 Mar 23; 21(2):71. PubMed ID: 35364659 [Abstract] [Full Text] [Related]
16. Generation of reactive oxygen species accounts for cytotoxicity of an endogenous dopaminergic neurotoxin, (R)-N-methylsalsolinol, to differentiated dopaminergic SH-SY5Y cells. Minami C, Deng Y, Maruyama W, Takahashi T, Kawai M, Nakahara D, Naoi M. J Neural Transm (Vienna); 1998 Mar 23; 105(4-5):397-405. PubMed ID: 9720969 [Abstract] [Full Text] [Related]